Mission
CESPU Diagnóstico, is a company created as a startup within the scope of the innovation developed in the IUCS research centers (initially called Targetalent) for the transfer of innovation. It resulted from a scientific research project, through which a new methodology for cytological diagnosis was developed, based on cytology and applied to telepathology.
The mission of CESPU Diagnóstico is to develop, implement, manufacture, and make available to the market medical devices in the diagnostic area based on cytological and molecular studies. The vision is to be a reference company, in the area of research, providing products and services that meet the requirements of manufacturing, clinical and laboratory diagnosis. Each partnership/business relationship is assured by commitment, rigor and quality, which are an integral part of the company.
BlueStain movie here.
An in vitro diagnostic medical device that meets high quality standards and allows you to stain a variety of cytological samples simply and quickly, with clear definition of cell structures, either in conventional or thinprep smears, fixed in alcohol or dried at room temperature. This medical device is a reliable clinical tool for the evaluation of the suitability, screening, and preliminary diagnosis of a variety of cytology specimens. Its application optimizes resource usage and puts the device at the disposal of all forms of screenable cancer through cytology.
The BlueStain® method consists of cytoplasmic and nuclear staining, which can be performed in just 2 minutes, allowing:
a) Definition of nuclear details, providing a perfect analysis of inflammatory and neoplastic changes.
b) Cytoplasmic transparency, of particular importance because of the different cell thicknesses and frequent cell overlap in the sample.
Highlight Publications
Ferreira, F., Alves, D., Oliveira, T., Coelho, S., Oliveira, I., & de Melo Alves, P. (2023). Evaluation of saliva as an alternative to standard collection for detection of SARS-CoV-2. Scientific Letters, 1(1), 3. https://doi.org/10.48797/sl.2023.0
De Melo Alves, P., Ferreira, F., Oliveira, T., Alves, D., Canberk, S., & Schmitt, F. C. (2023). A New Cytology Staining Method: A Fast Approach for Rapid On-Site Evaluation on Thyroid Fine-Needle Aspiration Cytology. Acta Cytologica, 67(3), 289–294. https://doi.org/10.1159/000527347
Applicable Technical Legislation
- Lei nº 58/2019 (Dados Pessoais);
- Decreto-Lei Nº 156/2005 (Livro de Reclamações);
- Regulation (EU) 2017/745 (Medical Devices);
- Regulation (EU) 2017/746 (Medical Devices in Vitro);
- EN ISO 14971:2012 (Application of Risk Management to Medical Devices).
Norm(s)
- NP 4457 - Management of Research, Development and Innovation (RDI)
- EN ISO 13485 - Medical devices - Quality management systems - Requirements for regulatory purposes
- NP EN ISO 9001 - Quality Management Systems.
Awards
CESPU Diagnóstico, S.A.
Rua Central de Gandra, 1317
4585-116 Gandra - Paredes - Portugal
Email: diagnostico@cespu.pt
Contact: +351 936 200 856
NIPC: 510221530 |
Leaders
Fernando Ferreira
Paula Melo
Mission
CESPU Diagnóstico, is a company created as a startup within the scope of the innovation developed in the IUCS research centers (initially called Targetalent) for the transfer of innovation. It resulted from a scientific research project, through which a new methodology for cytological diagnosis was developed, based on cytology and applied to telepathology.
The mission of CESPU Diagnóstico is to develop, implement, manufacture, and make available to the market medical devices in the diagnostic area based on cytological and molecular studies. The vision is to be a reference company, in the area of research, providing products and services that meet the requirements of manufacturing, clinical and laboratory diagnosis. Each partnership/business relationship is assured by commitment, rigor and quality, which are an integral part of the company.
Highlight Products
banner1.png
BlueStain movie here.
An in vitro diagnostic medical device that meets high quality standards and allows you to stain a variety of cytological samples simply and quickly, with clear definition of cell structures, either in conventional or thinprep smears, fixed in alcohol or dried at room temperature. This medical device is a reliable clinical tool for the evaluation of the suitability, screening, and preliminary diagnosis of a variety of cytology specimens. Its application optimizes resource usage and puts the device at the disposal of all forms of screenable cancer through cytology.
The BlueStain® method consists of cytoplasmic and nuclear staining, which can be performed in just 2 minutes, allowing:
a) Definition of nuclear details, providing a perfect analysis of inflammatory and neoplastic changes.
b) Cytoplasmic transparency, of particular importance because of the different cell thicknesses and frequent cell overlap in the sample.
Highlight Publications
Ferreira, F., Alves, D., Oliveira, T., Coelho, S., Oliveira, I., & de Melo Alves, P. (2023). Evaluation of saliva as an alternative to standard collection for detection of SARS-CoV-2. Scientific Letters, 1(1), 3. https://doi.org/10.48797/sl.2023.0
De Melo Alves, P., Ferreira, F., Oliveira, T., Alves, D., Canberk, S., & Schmitt, F. C. (2023). A New Cytology Staining Method: A Fast Approach for Rapid On-Site Evaluation on Thyroid Fine-Needle Aspiration Cytology. Acta Cytologica, 67(3), 289–294. https://doi.org/10.1159/000527347
Applicable Technical Legislation
- Lei nº 58/2019 (Dados Pessoais);
- Decreto-Lei Nº 156/2005 (Livro de Reclamações);
- Regulation (EU) 2017/745 (Medical Devices);
- Regulation (EU) 2017/746 (Medical Devices in Vitro);
- EN ISO 14971:2012 (Application of Risk Management to Medical Devices).
Norm(s)
- NP 4457 - Management of Research, Development and Innovation (RDI)
- EN ISO 13485 - Medical devices - Quality management systems - Requirements for regulatory purposes
- NP EN ISO 9001 - Quality Management Systems.
Awards
1401902137V3oVT4jd9Ny32LQ0.png
Selos20156.jpg
selos_arrisca-premiado.jpg
Contacts
Rua Central de Gandra, 1317
4585-116 Gandra - Paredes - Portugal
Email: diagnostico@cespu.pt
Contact: +351 936 200 856
NIPC: 510221530